CDC warns of COVID "rebound" after taking Paxlovid, says drug still beneficial

Key Facts

• CBS Evening News Updated on: May 31, 2022 / 7:45 AM / CBS News CDC warns of COVID "rebound" after Paxlovid CDC warns of COVID-19 "rebound" after Pfizer pill Paxlovid 02:07 As COVID-19 cases continue to rise, Paxlovid is being prescribed to try to keep high-risk patients out of the hospital.
• But the Centers for Disease Control and Prevention is warning of potential "COVID-19 rebound" after a five-day course of the treatment.
• There is currently no evidence that additional treatment is needed, according to the CDC, and Pfizer, the maker of Paxlovid, is not changing its dosage guidelines.
• Pfizer said it is currently seeing a rebound rate of about 2%, but is continuing to monitor patients Infectious disease expert Dr. David Ho tested positive for COVID-19 after attending a conference on the virus.

Click To Read Full Article